Current Management of Primary Pulmonary Hypertension

Author： de Backer T.L.M.   Smedema J-P.   Carlier S.G.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.12, 2001-01, pp. : 801-817

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab-Induced Hypertension: Pathogenesis and Management

By Syrigos Kostas N.  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 159-169

Adis International

Access to resources Recommend Favorite

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension

By Nakamura Kazufumi   Matsubara Hiromi   Akagi Satoshi   Sarashina Toshihiro   Ejiri Kentaro   Kawakita Norifumi   Yoshida Masashi   Miyoshi Toru   Watanabe Atsuyuki   Nishii Nobuhiro   Ito Hiroshi  

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-04 ,pp. : 48-48

MDPI

Access to resources Recommend Favorite

The role of an activity monitor in the objective evaluation of patients with pulmonary hypertension

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 119-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Management of Chordoma

By  

Current Drug Therapy, Vol. 5, Iss. 1, 2010-02 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Current Concepts on the Management of Chordoma

By  

Current Drug Therapy, Vol. 7, Iss. 4, 2012-12 ,pp. : 235-247

Bentham Science Publishers

Access to resources Recommend Favorite